Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04950894 · ClinicalTrials.gov registry record · NA
Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation
A NA study of Obstructive Sleep Apnea and OSA, sponsored by LivaNova.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 20
- Study locations
NCT04950894 is a NA study of Obstructive Sleep Apnea and OSA that is active but no longer recruiting, run by LivaNova. The registered enrollment target is 150 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (32% lower). The trial reports 20 study locations across 14 states.
The verdict
NCT04950894, a NA study of Obstructive Sleep Apnea and OSA, is active but no longer recruiting, sponsored by LivaNova.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 20
- Study locations
Study Summary
Multi-center, open-label, prospective, randomized clinical trial of the aura6000(R) System for the reduction of apnea and hypopneas in adult patients with moderate to severe obstructive sleep apnea who have failed or are unwilling to use positive airway pressure treatment.
Conditions Studied
Interventions
- DEVICE Hypoglossal Nerve Stimulation
Study Locations (20)
Arizona
- Banner Health - Phoenix
- University of Arizona - Tucson
California
- Sacramento Ent - Roseville
- Paul Schalch Lepe, Md/Silenso Clinic - San Diego
Florida
- Sleep Medicine Specialists of South Florida - Miami
- Morton Plant Mease Health Care - Safety Harbor
Pennsylvania
- Penn State Health - Hershey
- Philadelphia Ear, Nose and Throat Associates - Philadelphia
South Carolina
- Medical University of South Carolina - Charleston
- Bogan Sleep Consultants, Llc - Columbia
Texas
- Houston Methodist - Houston
- Epic Medical Research - Red Oak
Alabama
- University of Alabama At Birmingham - Birmingham
Georgia
- Advanced Ent Associates - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-07-27 |
| Est. Completion | 2025-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04950894
The ClinicalTrials.gov registry entry for NCT04950894 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (32% lower). The listed sponsor is LivaNova, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Hypoglossal Nerve Stimulation is the first listed.
NCT04950894 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Arizona, California, Florida.
Frequently Asked Questions
What is clinical trial NCT04950894 about?
NCT04950894 is a clinical study titled "Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation". Multi-center, open-label, prospective, randomized clinical trial of the aura6000(R) System for the reduction of apnea and hypopneas in adult patients with moderate to severe obstructive sleep apnea who have failed or are unwilling to use positive airway pressure treatment.
What is the current status of trial NCT04950894?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2021-07-27. Estimated completion is 2025-10-30.
What conditions does trial NCT04950894 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, OSA, Apnea, Obstructive Sleep, Apnea, Hypopnea, Sleep.
What interventions are being tested in trial NCT04950894?
The interventions under investigation include: Hypoglossal Nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT04950894?
This trial is sponsored by LivaNova, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04950894 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Mandibular Advancement Device and Changes in Nocturia
RECRUITING · NA
-
Severe Label Expansion for EVO Products Trial
RECRUITING · NA
-
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.